Coupling of the NMDA receptor to neuroprotective and neurodestructive events.
about
The impact of biosampling procedures on molecular data interpretationComputational investigation of the changing patterns of subtype specific NMDA receptor activation during physiological glutamatergic neurotransmissionNeuroprotective effects of a novel single compound 1-methoxyoctadecan-1-ol isolated from Uncaria sinensis in primary cortical neurons and a photothrombotic ischemia modelPCSK9 regulates neuronal apoptosis by adjusting ApoER2 levels and signalingProtein S protects neurons from excitotoxic injury by activating the TAM receptor Tyro3-phosphatidylinositol 3-kinase-Akt pathway through its sex hormone-binding globulin-like regionThe Effect of Noscapine on Oxygen-Glucose Deprivation on Primary Murine Cortical Neurons in High Glucose ConditionNeurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersIntrahippocampal administration of a domain antibody that binds aggregated amyloid-β reverses cognitive deficits produced by diet-induced obesity.Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain.Neuronal and nonneuronal COX-2 expression confers neurotoxic and neuroprotective phenotypes in response to excitotoxin challengeAstrocyte response to motor neuron injury promotes structural synaptic plasticity via STAT3-regulated TSP-1 expression.Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic miceEffects of natural antioxidants in neurodegenerative disease.Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6/2 model of Huntington disease.Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders.Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⁺ influx, mitochondrial instability, and Ca²⁺ overload.Calcium signaling in synapse-to-nucleus communicationCellular prion protein and NMDA receptor modulation: protecting against excitotoxicity.Transcriptional expression patterns triggered by chemically distinct neuroprotective molecules.Formaldehyde increases intracellular calcium concentration in primary cultured hippocampal neurons partly through NMDA receptors and T-type calcium channelsFunctional NMDA receptors with atypical properties are expressed in podocytesXENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia.Increased transforming growth factor-β1 modulates glutamate receptor expression in the hippocampusMitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons.A combinatorial approach of Proteomics and Systems Biology in unravelling the mechanisms of acute kidney injury (AKI): involvement of NMDA receptor GRIN1 in murine AKI.Forebrain striatal-specific expression of mutant huntingtin protein in vivo induces cell-autonomous age-dependent alterations in sensitivity to excitotoxicity and mitochondrial function.Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions.Oxygen/glucose deprivation induces a reduction in synaptic AMPA receptors on hippocampal CA3 neurons mediated by mGluR1 and adenosine A3 receptorsLoss of F-box only protein 2 (Fbxo2) disrupts levels and localization of select NMDA receptor subunits, and promotes aberrant synaptic connectivity.The dichotomy of memantine treatment for ischemic stroke: dose-dependent protective and detrimental effects.Calpain-mediated degradation of myocyte enhancer factor 2D contributes to excitotoxicity by activation of extrasynaptic N-methyl-D-aspartate receptorsScaffolding protein Homer1a protects against NMDA-induced neuronal injury.Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers.Sustained activation of N-methyl-D-aspartate receptors in podoctyes leads to oxidative stress, mobilization of transient receptor potential canonical 6 channels, nuclear factor of activated T cells activation, and apoptotic cell death.Identification of an N-methyl-D-aspartate receptor in isolated nervous system mitochondriaNeurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.C-terminal domains of N-methyl-D-aspartic acid receptor modulate unitary channel conductance and gatingRas family small GTPase-mediated neuroprotective signaling in stroke.Regulation of Ras proteins by reactive nitrogen species.Pituitary adenylate cyclase-activating peptide induces long-lasting neuroprotection through the induction of activity-dependent signaling via the cyclic AMP response element-binding protein-regulated transcription co-activator 1.
P2860
Q26991764-B59EAF9A-3170-42D6-AAFD-61B2B088D97BQ28478887-4D672ED2-53D7-4B42-9DB7-2272CA37BDA4Q28538531-9894E852-8991-42F6-AA1E-2E03B0ED6DF2Q28586625-FD5E3E97-F045-41FF-93AF-DC55AB85E032Q28592005-E27D8E5B-BB95-42BB-BAD0-3C43D1AC7B8FQ28830706-B8E375A7-A211-4DEF-8F22-B3FF12CBB5DEQ29615839-2D5933F8-03E7-4328-8E3B-4837BA9FB26AQ30277159-04BC9A3C-FE3F-4B34-8453-48EEC3F4F48BQ30437957-8820C8FE-90D8-4CF6-85EB-80C13DAE30C6Q33859381-4063AD76-9833-48F0-B473-95DD376B9A8BQ33924097-AB24CF2A-F9C2-4686-A617-A55FD395E49EQ34017941-955BD9DC-1DCE-4D4D-A3CE-D99554630B61Q34030539-D2D4481C-E347-4354-B788-771EAAD43A52Q34126315-DCCD2E0B-E626-4C6C-A172-8E1B699EF941Q34138025-238712F3-7AF2-47AC-904C-EDD47FE6842AQ34197724-A2D65ED5-5629-409C-84FF-829128B68908Q34203749-3316A398-6938-4EA8-A72F-9CBB07E7B63EQ34391341-F0B94913-4C22-403C-BB2A-E3C69D742D66Q34417114-E949A378-B3F3-4B86-B96B-EBE0403951D1Q34480520-18B25921-E89B-4439-911D-80CF379D33F3Q34501710-44A76493-99E9-4829-B251-68905422CBEDQ34570042-C504B482-43A8-4E28-AE41-9C13585952E3Q34747895-72A2F901-D50D-4AFC-94C3-3BB468075DCAQ34772619-FCC05E61-88DC-4976-8156-EA261DF1F7A6Q35029014-1483BE55-A093-47C8-BC6D-EAE49C5C8131Q35161675-616A24AD-1462-49FE-AF15-7DBC84ABB6C1Q35172510-6B6B6510-506B-4297-ACC0-CB2435B1076DQ35178516-93B6D472-A822-4947-8274-80743A839A21Q35423787-87CFEFB2-4D56-406D-A1A3-DEFAAD10B0CDQ35591224-57D87C04-A00C-4AAB-BAAF-99A3BF754531Q35774086-24506F7D-6BEF-487E-BD3D-29056EC4BA10Q36022288-C9E8FA50-E0F7-429D-8CA5-6F8B3E3398D7Q36026546-693DEB6E-1865-4C10-8FA6-5FE1B9DFBF38Q36294421-5F47A67F-F5C1-42BD-A937-C00533300E70Q36318758-C9E2A27C-8546-4807-A3D2-36907B2B28A9Q36330297-6699A887-D164-400E-97BA-C5CD6348AA28Q36332821-93992A26-4433-419C-97B3-820FEF787B24Q36403779-A5812228-DEE5-407A-A8D1-19A3342EC0CEQ36546362-5E0B377D-BD76-4E27-8B81-4239FC1B9362Q36569944-A7B8402E-00FD-4301-B0B6-A00DBEAA98FD
P2860
Coupling of the NMDA receptor to neuroprotective and neurodestructive events.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Coupling of the NMDA receptor to neuroprotective and neurodestructive events.
@ast
Coupling of the NMDA receptor to neuroprotective and neurodestructive events.
@en
type
label
Coupling of the NMDA receptor to neuroprotective and neurodestructive events.
@ast
Coupling of the NMDA receptor to neuroprotective and neurodestructive events.
@en
prefLabel
Coupling of the NMDA receptor to neuroprotective and neurodestructive events.
@ast
Coupling of the NMDA receptor to neuroprotective and neurodestructive events.
@en
P2860
P356
P1476
Coupling of the NMDA receptor to neuroprotective and neurodestructive events.
@en
P2860
P304
P356
10.1042/BST0371147
P577
2009-12-01T00:00:00Z